
Maxcore Pharma Private Limited
About Maxcore Pharma Private Limited
Data last updated:
Maxcore Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 31 October 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2023PTC422149.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Virendra Singh Parmar and Manohar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Houseno Cn 87 Khasra No, 10/2 Roop Nagar Gali No6, New Delhi, Delhi, India – 110041.
Company details
Contact details
Maxcore Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressHouseno Cn 87 Khasra No, 10/2 Roop Nagar Gali No6, New Delhi, Delhi, India – 110041
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Maxcore Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Maxcore Pharma Private Limited, buy the company report.
Board of directors of Maxcore Pharma Private Limited
Maxcore Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virendra Singh Parmar | Director | 31 Oct 2023 | 3 Years 0 Months | Current |
| Manohar Singh | Director | 31 Oct 2023 | 3 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Maxcore Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxcore Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maxcore Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maxcore Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Manohar Singh was appointed as Director on 31 Oct 2023.
Frequently asked questions
Maxcore Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in science research, within the research and development industry. It was incorporated on 31 October 2023 (3+ years old) and is registered under CIN U73100DL2023PTC422149.
Maxcore Pharma has 2 current directors:
- Virendra Singh Parmar - Director
- Manohar Singh - Director
The latest financial statements of Maxcore Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Maxcore Pharma is U73100DL2023PTC422149. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxcore Pharma was incorporated on 31 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Manohar Singh was appointed as Director on 31 Oct 2023. Virendra Singh Parmar was appointed as Director on 31 Oct 2023.
The registered office of Maxcore Pharma is at Houseno Cn 87 Khasra No, 102 Roop Nagar Gali No6, New Delhi, Delhi, India – 110041.
Maxcore Pharma operates in the research and development industry, in the science research segment.
Maxcore Pharma can be reached at its registered office: Houseno Cn 87 Khasra No, 102 Roop Nagar Gali No6, New Delhi, Delhi, India – 110041.
Maxcore Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

